Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$566.7K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Mar 13 | VERA | Vera Therapeutics, Inc. | MEXER◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 13 | VERA | Vera Therapeutics, Inc. | MEXER | 10,000 | $3.94 | $39.4K | +15.2% | Open the original filing on SEC.gov |
| Feb 23 | VERA | Vera Therapeutics, Inc. | SSELL | 3,117 | $41.98 | $130.9K | -4.6% | Open the original filing on SEC.gov |
| Feb 4 | VERA | Vera Therapeutics, Inc. | AGRANT◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 4 | VERA | Vera Therapeutics, Inc. | AGRANT | 10,000 | — | — | +17.3% | Open the original filing on SEC.gov |
| Nov 13, 2025 | VERA | Vera Therapeutics, Inc. | MEXER◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 13, 2025 | VERA | Vera Therapeutics, Inc. | MEXER | 10,000 | $3.94 | $39.4K | +20.9% | Open the original filing on SEC.gov |
| Nov 11, 2025 | VERA | Vera Therapeutics, Inc. | SSELL | 15,000 | $29.06 | $435.9K | -23.9% | Open the original filing on SEC.gov |